Effects of a phasic oral contraceptive containing desogestrel on facial seborrhea and acne

The combined oral contraceptive containing ethinylestradiol and the selective progestogen, desogestrel, in a phasic regimen (DSG-OC, Tri-merci®) has been shown to reduce facial oiliness. This study was designed to evaluate further the effects of this OC on the skin of women with facial seborrhea and...

Full description

Saved in:

Bibliographic Details
Published in:	Contraception (Stoneham) Vol. 68; no. 4; pp. 239 - 245
Main Authors:	Prilepskaya, V.N., Serov, V.N., Zharov, E.V., Golousenko, I.J., Mejevitinova, E.A., Gogaeva, E.V., Yaglov, V.V., Golubeva, O.N.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-10-2003
Subjects:	Acne Acne Vulgaris - drug therapy Acne Vulgaris - pathology Adolescent Adult Contraceptives, Oral, Combined - administration & dosage Contraceptives, Oral, Combined - therapeutic use Desogestrel Desogestrel - administration & dosage Ethinyl Estradiol - administration & dosage Female Humans Oral contraceptive Russia Seborrhea Severity of Illness Index Skin Treatment Outcome Russia Desogestrel Seborrhea Skin Oral contraceptive Acne
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The combined oral contraceptive containing ethinylestradiol and the selective progestogen, desogestrel, in a phasic regimen (DSG-OC, Tri-merci®) has been shown to reduce facial oiliness. This study was designed to evaluate further the effects of this OC on the skin of women with facial seborrhea and mild or moderate acne. This was an open, noncomparative, bicenter study in 60 healthy Russian women, aged 18–30 years, with facial seborrhea and mild or moderate facial acne, who wished to use oral contraception. All women received the OC containing desogestrel (50/100/150 μg) and ethinylestradiol (35/30/30 μg) for three phases of 7 days followed by a 7-day pill-free interval, for six cycles. Seborrhea was assessed using the Sebutape® technique, in which strips of adhesive microporous polymeric film pressed onto facial sites are used to assess sebaceous activity. Acne was assessed by counting facial lesions. Subjective evaluations of skin and hair condition, patients' feelings to them and satisfaction with the OC were made using a visual analogue scale (VAS). Assessments were made at baseline, and after one, three and six treatment cycles. Sebutape assessments of seborrhea were significantly improved, on the right and left cheeks, after one treatment cycle, and on the forehead after three treatment cycles. These improvements increased steadily and were much larger at the end of Cycle 6. Acne grades were significantly improved after three and six treatment cycles. VAS scores in response to questions dealing with self-esteem and self-confidence were significantly improved after three cycles and in some cases after just one cycle. The women's views of their skin and hair (greasiness) were correspondingly significantly improved. Subjective assessments indicated that after one, three and six cycles, 69%, 93% and 98%, respectively, of women were satisfied or very satisfied with the DSG-OC. In women with facial seborrhea and mild or moderate acne, the use of DSG-OC appears to improve seborrhea after just one cycle and acne grades after three cycles. These improvements are accompanied by increases in self-esteem and confidence.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0010-7824 1879-0518
DOI:	10.1016/S0010-7824(03)00167-7